Z-0462-2022 Class II Terminated

Recalled by Abbott Molecular, Inc. — Des Plaines, IL

FDA device recall Z-0462-2022 was initiated by Abbott Molecular, Inc. on Dec 6, 2021 and is designated Class II. Reason for recall: There is a software defect that can cause the Amplification Detection clamp CLEAN position to be set too high. The recall status is terminated (terminated Aug 14, 2026). Affected quantity: 742 devices.

Recall Details

Product Type
Devices
Report Date
Jan 12, 2022
Initiation Date
Dec 6, 2021
Termination Date
Aug 14, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
742 devices

Product Description

Alinity m System, Part No. 08N53-002

Reason for Recall

There is a software defect that can cause the Amplification Detection clamp CLEAN position to be set too high.

Distribution Pattern

Worldwide distribution - US distribution and the countries of Australia, Austria, Belgium, Brazil, Cambodia, Canada, Chile, Colombia, Czech Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Malawi, Malaysia, Mexico, Montenegro, Morocco, Mozambique, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Uganda, United Kingdom, and Vietnam

Code Information

Alinity m System, Model 08N53-002, all serial numbers

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0462-2022
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.